Form 4 for ENOV Enovis CORP
Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-15 · accession 0001209191-22-057656 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-17 | 2022-11-15 | ENOV | PRYOR DANIEL A | EVP, Strategy, Business Dev | S - Sale+OE | $54.58 | -67.4K | 75.7K | -47% | -$3.68M |
| D | 2022-11-17 | 2022-11-15 | ENOV | PRYOR DANIEL A | EVP, Strategy, Business Dev | M - OptEx | $45.06 | +67.4K | 143.2K | +89% | +$3.04M |
| D | 2022-11-17 | 2022-11-15 | ENOV | PRYOR DANIEL A | EVP, Strategy, Business Dev | M - OptEx | $0.00 | -67.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2022-11-15 | S | D | 67,421 | $54.58 | 75,731 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. (F3) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.47 to $55.01, inclusive. The reporting person undertakes to provide to Enovis Corporation, any security holder of Enovis Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common stock, par value $0.001 | 2022-11-15 | M | A | 67,421 | $45.06 | 143,152 | D | — | — | (F1) Holdings reflect the adjustments that occurred as of April 4, 2022 in connection with the spin-off of ESAB Corporation by the Issuer. In connection with the spin-off, each outstanding restricted stock unit was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded down to the nearest whole unit. In addition, holdings have been updated to reflect the impact of the one-for-three reverse stock split effected by the Issuer on April 4, 2022. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2022-11-15 | M | D | 67,421 | $0.00 | 0 | D | $45.06 · — to 2023-11-16 | 67,421 Common stock, par value $.001 | (F4) The option vests in equal installments on the first, second and third anniversaries of the grant date, which was 11/15/2015 |